| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |